CEL-SCI Corp. CEO Buys $180,000 in Stock (CVM)
CEL-SCI Corp. (NYSE:CVM) CEO Geert Kersten acquired 300,000 shares of the stock in a transaction that occurred on Monday, December 30th. The stock was purchased at an average price of $0.60 per share, for a total transaction of $180,000.00. Following the purchase, the chief executive officer now directly owns 725,227 shares in the company, valued at approximately $435,136. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of CEL-SCI Corp. (NYSE:CVM) traded up 8.11% on Thursday, hitting $0.6399. 957,400 shares of the company’s stock traded hands. CEL-SCI Corp. has a 52 week low of $0.53 and a 52 week high of $3.10. The stock has a 50-day moving average of $0.73 and a 200-day moving average of $1.49. The company’s market cap is $31.8 million.
CEL-SCI Corporation (NYSE:CVM) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.